Thousands of hospitals, large and small, are girding for cuts to their Medicare payments in 2014, as federal pay-for-performance programs aimed at boosting clinical quality, improving patient experience and preventing unnecessary hospital readmissions roll into their second year.
Thousands of hospitals, large and small, are girding for cuts to their Medicare payments in 2014, as federal pay-for-performance programs aimed at boosting clinical quality, improving patient experience and preventing unnecessary hospital readmissions roll into their second year.
Officials at many hospitals, particularly academic medical centers, say they also fear an additional financial hit that may come next October, when the CMS is scheduled to launch the third and final pay-for-performance program established by the Patient Protection and Affordable Care Act. That initiative, the hospital-acquired condition reduction program, will reduce fiscal 2015 Medicare payments by 1% for hospitals that fall within the worst-performing quartile, based on measures of adverse events that occur during hospital stays, including infections and pressure ulcers.
Together with the CMS' value-based purchasing and readmissions reduction programs, both of which began in fiscal 2013, the three initiatives are part of a sweeping effort to move the agency toward paying for high-value care. While quality experts and hospital leaders laud the goals of the HAC reduction program, they have a lengthy list of concerns, including issues with the measures the CMS chose, the potential for multiple penalties under overlapping programs, and the prospect that teaching hospitals will be disproportionately affected. They question whether the programs will actually help hospitals achieve better quality care, and warn that the combined impact of penalties from three pay-for-performance programs could hurt some hospitals.
Read the full story here: http://bit.ly/1aOd6SU
Source: Modern Healthcare
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
April 17th 2025Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at diagnosis, resulting in delayed chemotherapy initiation and highlighting the need for more inclusive guidelines.
Read More